<?xml version="1.0" encoding="UTF-8"?>
<article-meta class="article-meta">
 <article-id pub-id-type="pmcid" class="article-id">320490</article-id>
 <article-id pub-id-type="publisher-id" class="article-id">1475-2832-3-1</article-id>
 <article-id pub-id-type="pmid" class="article-id">14711381</article-id>
 <article-id pub-id-type="doi" class="article-id">10.1186/1475-2832-3-1</article-id>
 <article-categories class="article-categories">
  <div subj-group-type="heading" class="subj-group" xmlns="http://www.w3.org/1999/xhtml">
   <span class="subject">Primary Research</span>
  </div>
 </article-categories>
 <title-group class="title-group">
  <div class="article-title" xmlns="http://www.w3.org/1999/xhtml">Behavioral and antioxidant activity of a tosylbenz[g]indolamine derivative. A proposed better profile for a potential antipsychotic agent</div>
 </title-group>
 <div class="contrib-group" xmlns="http://www.w3.org/1999/xhtml">
  <contrib id="A1" corresp="yes" contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Zika</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Chara A</span>
   </name>
   <a ref-type="aff" rid="I1" href="#I1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <span class="email" xmlns="http://www.w3.org/1999/xhtml">chzika@pharm.auth.gr</span>
  </contrib>
  <contrib id="A2" contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Nicolaou</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Ioannis</span>
   </name>
   <a ref-type="aff" rid="I1" href="#I1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <span class="email" xmlns="http://www.w3.org/1999/xhtml">Inicolao@pharm.auth.gr</span>
  </contrib>
  <contrib id="A3" contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Gavalas</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Antonis</span>
   </name>
   <a ref-type="aff" rid="I1" href="#I1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <span class="email" xmlns="http://www.w3.org/1999/xhtml">vdem@pharm.auth.gr</span>
  </contrib>
  <contrib id="A4" contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Rekatas</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">George V</span>
   </name>
   <a ref-type="aff" rid="I1" href="#I1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <span class="email" xmlns="http://www.w3.org/1999/xhtml">vdem@pharm.auth.gr</span>
  </contrib>
  <contrib id="A5" contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Tani</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Ekaterini</span>
   </name>
   <a ref-type="aff" rid="I1" href="#I1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <span class="email" xmlns="http://www.w3.org/1999/xhtml">vdem@pharm.auth.gr</span>
  </contrib>
  <contrib id="A6" contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Demopoulos</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Vassilis J</span>
   </name>
   <a ref-type="aff" rid="I1" href="#I1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <span class="email" xmlns="http://www.w3.org/1999/xhtml">vdem@pharm.auth.gr</span>
  </contrib>
 </div>
 <aff id="I1" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">1</span>Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 54124 Greece
 </aff>
 <pub-date pub-type="collection" class="pub-date">
  <span class="year" xmlns="http://www.w3.org/1999/xhtml">2004</span>
 </pub-date>
 <pub-date pub-type="epub" class="pub-date">
  <span class="day" xmlns="http://www.w3.org/1999/xhtml">7</span>
  <span class="month" xmlns="http://www.w3.org/1999/xhtml">1</span>
  <span class="year" xmlns="http://www.w3.org/1999/xhtml">2004</span>
 </pub-date>
 <span class="volume" xmlns="http://www.w3.org/1999/xhtml">3</span>
 <span class="fpage" xmlns="http://www.w3.org/1999/xhtml">1</span>
 <span class="lpage" xmlns="http://www.w3.org/1999/xhtml">1</span>
 <span ext-link-type="uri" xlink:href="http://www.general-hospital-psychiatry.com/content/3/1/1" class="ext-link" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <history class="history">
  <date date-type="received" class="date">
   <span class="day" xmlns="http://www.w3.org/1999/xhtml">29</span>
   <span class="month" xmlns="http://www.w3.org/1999/xhtml">11</span>
   <span class="year" xmlns="http://www.w3.org/1999/xhtml">2002</span>
  </date>
  <date date-type="accepted" class="date">
   <span class="day" xmlns="http://www.w3.org/1999/xhtml">7</span>
   <span class="month" xmlns="http://www.w3.org/1999/xhtml">1</span>
   <span class="year" xmlns="http://www.w3.org/1999/xhtml">2004</span>
  </date>
 </history>
 <div class="permissions" xmlns="http://www.w3.org/1999/xhtml">
  <span class="copyright-statement">Copyright Â© 2004 Zika et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</span>
  <span class="copyright-year">2004</span>
  <span class="copyright-holder">Zika et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</span>
 </div>
 <div class="abstract" xmlns="http://www.w3.org/1999/xhtml">
  <sec class="sec" xmlns="">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Background</div>
   <p xmlns="http://www.w3.org/1999/xhtml">Tardive dyskinesia (TD) is a major limitation of older antipsychotics. Newer antipsychotics have various other side effects such as weight gain, hyperglycemia, etc. In a previous study we have shown that an indolamine molecule expresses a moderate binding affinity at the dopamine D
    <sub>2 </sub>and serotonin 5-HT
    <sub>1A </sub>receptors in in vitro competition binding assays. In the present work, we tested its p-toluenesulfonyl derivative (TPBIA) for behavioral effects in rats, related to interactions with central dopamine receptors and its antioxidant activity.
   </p>
  </sec>
  <sec sec-type="methods" class="sec" xmlns="">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Methods</div>
   <p xmlns="http://www.w3.org/1999/xhtml">Adult male Fischer-344 rats grouped as: i) Untreated rats: TPBIA was administered i.p. in various doses ii) Apomorphine-treated rats: were treated with apomorphine (1 mg kg
    <span class="sup">-1</span>, i.p.) 10 min after the administration of TPBIA. Afterwards the rats were placed individually in the activity cage and their motor behaviour was recorded for the next 30 min The antioxidant potential of TPBIA was investigated in the model of in vitro non enzymatic lipid peroxidation.
   </p>
  </sec>
  <sec class="sec" xmlns="">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Results</div>
   <p xmlns="http://www.w3.org/1999/xhtml">i) In non-pretreated rats, TPBIA reduces the activity by 39 and 82% respectively, ii) In apomorphine pretreated rats, TPBIA reverses the hyperactivity and stereotype behaviour induced by apomorphine. Also TPBIA completely inhibits the peroxidation of rat liver microsome preparations at concentrations of 0.5, 0.25 and 0.1 mM.</p>
  </sec>
  <sec class="sec" xmlns="">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Conclusion</div>
   <p xmlns="http://www.w3.org/1999/xhtml">TPBIA exerts dopamine antagonistic activity in the central nervous system. In addition, its antioxidant effect is a desirable property, since TD has been partially attributed, to oxidative stress. Further research is needed to test whether TPBIA may be used as an antipsychotic agent.</p>
  </sec>
 </div>
</article-meta>
